Nanoemulsion vaccines shift Th2-dominant allergy responses toward Th1 signaling to reduce allergic reactions and build tolerance.
Freeze-drying 3D-printed edible hydrogels helps preserve probiotic viability and supports shelf-stable products for at least three months.
Using water-insoluble thermoplastic compounds, the case addresses residual VOC entrapment while supporting stable dispersions for active-agent delivery.
3D-printed hollow microspheres support drug loading and controlled release while enabling embolization across different vessel sizes.
Bead milling and high-pressure homogenization produce specified steroid PSDs while surfactants limit flocculation and agglomeration.
Carbohydrate-targeted nanostructures deliver PKC inhibitors to the liver for septic cholestasis while minimizing systemic immune suppression.
Fast molecular tumbling limits chelate agents, so a thin T1 coating on nanoparticle supports raises surface-to-volume ratio for clearer MRI images.
Existing aqueous topiramate solutions can degrade; anhydrous glycerin and polyethylene glycol support a stable, ready-to-use oral liquid.
Phospholipid-cholesterol hybrid vesicles use pH-responsive amphiphiles to retain hemoglobin payloads while tuning oxygen transport.
See how tail-branched bioreducible lipidoid 306-O12B helps LNPs deliver Cas9 mRNA for lung or liver gene knockdown.
Click chemistry creates a glucosylated albumin nanoplatform for GLUT-targeted macrophages, suppressing inflammation and cell death.
Melt-blended additives create a strained thermoplastic pore network for rapid micropore and sustained nanopore release.
Sepiolite, edible oils, and additives stabilize 3-nitrooxypropanol powder formulations, achieving at least 70% retention.
Targeted lipid nanoparticles inhibit miRNA packaging while preserving normal homeostasis.
See how alkali metal salts stabilize and solubilize incompatible APIs in aqueous fills for softgels and other dosage forms.
Selective purification removes alkaloids and aglycones, while enteric coating preserves glycosides for intestinal release.
Silica microparticles penetrate the stratum corneum, enabling simpler delivery of large molecules with minimal skin damage.
A contracting fibrous structure fuses lipid nanoparticles without PEG or added ions.
Pamoic acid or sodium pamoate reduces dough adherence to molds, supporting consistent industrial soft chew production.
A cavity for the removable cap and a narrower recess for the container body support adaptable planetary-mixer compounding.
Modified aptamers target microvesicle antigens for precise cancer diagnostics and therapy.
This case examines dapsone dosing and delivery forms to reduce inflammatory responses and help prevent hospitalization and intubation.
This composition uses biodegradable crushed shells to improve poorly soluble active substances through sorption.
This spray-drying method produces high-yield nano-in-micro siRNA powder while limiting thermal loss and preserving particle properties.
This case uses alkaline pH, buffering, and sugar alcohols to stabilize glyburide, limit tubing sorption, and improve dose accuracy.
Crosslinked oligolysine-PEG coatings protect DNA nanostructures from nucleases.
Dry powder surfactants enable stable lung delivery without intubation.
This case uses non-natural peptide linkers to favor tumor proteolysis and limit premature cytotoxic drug release in normal tissue.
This case uses 1,000–5,000 g/mol amorphous substances and glass-transition criteria to limit polymer while reducing disintegration time.
A one-hour IV sotalol loading protocol accelerates oral dose escalation and supports discharge after focused QTc monitoring.
A premeasured two-chamber kit mixes short- and long-acting anesthetics at administration, extending analgesia while limiting toxicity.
Nucleic acid vaccination enables rapid production and temperature-stable SARS-CoV-2 protection.
Dry powder treprostinil enables higher-dose inhalation with fewer breath treatments.
A calcium-crosslinked Jelly fig pectin hydrogel withstands stomach and small-intestine enzymes, then releases agents in the colon.
This case combines low-molecular-weight PEI with lipid moieties to improve transfection while limiting cytotoxicity.
Controlled-size eggshell membrane particles target excess MMP activity and inflammation to support chronic wound healing.
Peptide compositions target airway inflammation and hyperresponsiveness with fewer side effects.
This case uses biodegradable anionic manganese oxide nanoparticles to bind cell-free nucleic acids and reduce inflammation.
UVA photochemical synthesis and LED size-focusing produce stable Au22 clusters for ROS generation, PDT, and photocatalysis.
A staged freezing and drying cycle supports higher protein vial fills, consistent cake structure, and faster reconstitution.
Alkalization, pH adjustment, and freeze-drying create an oral arsenic trioxide formulation with IV-comparable bioavailability.
Natural cross-linkers create drug-loaded polymer microspheres for smoother catheter delivery.
A reaction vessel, compact storage system, and mixing chamber deliver controlled inhaled NO without complex hospital infrastructure.
This case converts viscous liquid oleoresins into powder exceeding 60% concentration, improving stability, uniformity, and bioavailability.
This case pairs mealtime ultrarapid insulin with timed glargine to improve glucose control while limiting excursions and hypoglycemia.
HPMC-AS and PVP/VA dispersions improve cabozantinib solubility, stabilizing exposure and enabling lower doses with less GI toxicity.
Cyclodextrin and propylene glycol formulations address 25HC3S solubility, storage stability, isotonicity, and toxicity challenges.
This case combines a sealed container, hold-down members, and desiccant to preserve medication viability during storage and transport.
RSNO donors on and within mesoporous silica support high NO payloads and release up to 20 days without particle leaching.
This case shows how purified Dipsaci radix EVs enter BMSCs, promote osteogenic differentiation, and provide bone targetability.